Pharmacokinetics of berberine, palmatine, coptisine, epiberberine and jatrorrhizine from Coptidis Rhizoma in diabetic rats

Journal of China Pharmaceutical University

Volumn 39, Issue 6, 2008, Pages 526-529

  Yu, Sen ^a,b   Yu, Yun Li ^a   Lu, Shou Si ^a   Liu, Li ^a   Liu, Xiao Dong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Jiangsu Simcere Pharmaceutical R and D Co Ltd   (China)

Author keywords

Coptidis Rhizoma; Diabetes mellitus; Pharmacokinetics; Protoberberine type alkaloids

Indexed keywords

ALKALOID; BERBERINE; COPTIS RHIZOME EXTRACT; COPTISINE; EPIBERBERINE; JATRORRHIZINE; PALMATINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; RAT; STREPTOZOCIN DIABETES; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 61349156137     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Chen QM, Xie MZ. Acta Pharm Sin,1986, 21(6): 401-406.
2. Hou DH, Li L, Wang QJ, J China Pharm Univ,1983, 14 (1):30-33.
3. Shigeta K, Ootaki K, Tatemoto H, et al. Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by a Coptidis Rhizoma extract and protoberberine alkaloids[J]. Biosci Biotechnol Biochem, 2002, 66 (11): 2 491-2 494.
4. Kong WJ, Wei J, Abidi P, et al. Berberine is a novel cholesteroli lowering drug working through a unique mechanism distinct from statins[J]. Nat Med,2004, 10(12):1 344-1 351.
5. Sheng MP, Sun Q, Wang H. Chin Pharmacol Bull,1993, 9(1):64-67.
6. Lu T, Liang Y, Song J, et al. Simultaneous determination of berberine and palmatine in rat plasma by HPLC-ESI-MS after oral administration of traditional Chinese medicinal preparation Huang-Lian-Jie-Du decoction and the pharmacokinetic application of the method [J]. J Pharm Biomed Anal, 2006, 40 (5): 1 218-1 224.
7. Chinese source.
8. Liu F, Zhang H, Fang QM, Chin Tradit Pat Med),2005, 27 (12): 1 393-1 396.
9. Yu S, Pang XY, Deng YX, et al. A sensitive and specific liquid chromatography mass spectrometry method for simultaneous determination of Berberine, Palmatine, Coptisine, Epiberberine and Jatrorrhizine from Coptidis Rhizoma in rat plasma [J]. Int J Mass Spectrom,2007, 268(1):30-37.
10. Mehvar R. Effect of experimental diabetes mellitus on the pharmacokinetics of atenolol enantiomers in rats [J]. J Pharm Sci, 1991, 80(3):207-211.
11. Kim YC, Oh EY, Kim SH, et al. Pharmacokintics of diclofenac in rat model of diabetes mellitus induced by alloxan or steptozotocin [J]. Biopharm Drug Dispos,2006, 27(2):85-92.
12. Bae SK, Yang SH, Lee SJ,et al. Pharmacokinetic changes of DA7867, a new oxazolidinone, after intravenous and oral administration to rats with short-term and long-term diabetes mellitus induced by streptozotocin [J]. Eur J Pharm Sci, 2005, 25 (2-3): 337-345.